232 related articles for article (PubMed ID: 33538833)
1. Genetic or Toxicant-Induced Disruption of Vesicular Monoamine Storage and Global Metabolic Profiling in Caenorhabditis elegans.
Bradner JM; Kalia V; Lau FK; Sharma M; Bucher ML; Johnson M; Chen M; Walker DI; Jones DP; Miller GW
Toxicol Sci; 2021 Apr; 180(2):313-324. PubMed ID: 33538833
[TBL] [Abstract][Full Text] [Related]
2. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.
Duerr JS; Frisby DL; Gaskin J; Duke A; Asermely K; Huddleston D; Eiden LE; Rand JB
J Neurosci; 1999 Jan; 19(1):72-84. PubMed ID: 9870940
[TBL] [Abstract][Full Text] [Related]
3. A splice variant of the Drosophila vesicular monoamine transporter contains a conserved trafficking domain and functions in the storage of dopamine, serotonin, and octopamine.
Greer CL; Grygoruk A; Patton DE; Ley B; Romero-Calderon R; Chang HY; Houshyar R; Bainton RJ; Diantonio A; Krantz DE
J Neurobiol; 2005 Sep; 64(3):239-58. PubMed ID: 15849736
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.
German DC; Liang CL; Manaye KF; Lane K; Sonsalla PK
Neuroscience; 2000; 101(4):1063-9. PubMed ID: 11113355
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine Exposure during Embryogenesis Alters Expression and Function of Tyrosine Hydroxylase and the Vesicular Monoamine Transporter in Adult
Ke T; Poquette KE; Amro Gazze SL; Carvelli L
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673805
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
Staal RG; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
[TBL] [Abstract][Full Text] [Related]
8. β-Phenylethylamine requires the dopamine transporter to increase extracellular dopamine in Caenorhabditis elegans dopaminergic neurons.
Hossain M; Wickramasekara RN; Carvelli L
Neurochem Int; 2014 Jul; 73():27-31. PubMed ID: 24161617
[TBL] [Abstract][Full Text] [Related]
9. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
Erickson JD; Schafer MK; Bonner TI; Eiden LE; Weihe E
Proc Natl Acad Sci U S A; 1996 May; 93(10):5166-71. PubMed ID: 8643547
[TBL] [Abstract][Full Text] [Related]
10. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.
Fon EA; Pothos EN; Sun BC; Killeen N; Sulzer D; Edwards RH
Neuron; 1997 Dec; 19(6):1271-83. PubMed ID: 9427250
[TBL] [Abstract][Full Text] [Related]
11. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
[TBL] [Abstract][Full Text] [Related]
12. The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.
Speciale SG; Liang CL; Sonsalla PK; Edwards RH; German DC
Neuroscience; 1998 Jun; 84(4):1177-85. PubMed ID: 9578404
[TBL] [Abstract][Full Text] [Related]
13. Identified neurons in C. elegans coexpress vesicular transporters for acetylcholine and monoamines.
Duerr JS; Gaskin J; Rand JB
Am J Physiol Cell Physiol; 2001 Jun; 280(6):C1616-22. PubMed ID: 11350757
[TBL] [Abstract][Full Text] [Related]
14. Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity.
Bucher ML; Dunn AR; Bradner JM; Egerton KS; Burkett JP; Johnson MA; Miller GW
Eur J Neurosci; 2024 May; 59(10):2483-2501. PubMed ID: 38532289
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
[TBL] [Abstract][Full Text] [Related]
16. Normal biogenesis and cycling of empty synaptic vesicles in dopamine neurons of vesicular monoamine transporter 2 knockout mice.
Croft BG; Fortin GD; Corera AT; Edwards RH; Beaudet A; Trudeau LE; Fon EA
Mol Biol Cell; 2005 Jan; 16(1):306-15. PubMed ID: 15496457
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.
Henry JP; Botton D; Sagne C; Isambert MF; Desnos C; Blanchard V; Raisman-Vozari R; Krejci E; Massoulie J; Gasnier B
J Exp Biol; 1994 Nov; 196():251-62. PubMed ID: 7823026
[TBL] [Abstract][Full Text] [Related]
18. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
19. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Staal RG; Yang JM; Hait WN; Sonsalla PK
Brain Res; 2001 Aug; 910(1-2):116-25. PubMed ID: 11489261
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.
Nirenberg MJ; Chan J; Liu Y; Edwards RH; Pickel VM
J Neurosci; 1996 Jul; 16(13):4135-45. PubMed ID: 8753875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
